Literature DB >> 6811122

Interaction of pseudomonas exoproducts with phagocytic cells.

B Weber, M M Nickol, K S Jagger, C B Saelinger.   

Abstract

Polymorphonuclear leukocytes play the major role in host defense against infections with Pseudomonas aeruginosa; however, mononuclear cells also may contribute to defense against pulmonary infections with P. aeruginosa. Therefore, we examined the effects of three extracellular products of P. aeruginosa, exotoxin A, alkaline protease, and elastase, on the function of phagocytic cells. Phagocytosis or killing, protein synthesis, and membrane integrity were used as assays of cellular function. Pseudomonas toxin readily inhibited protein synthesis in mouse peritoneal macrophages; in contrast, proteolytic enzymes did not alter protein synthesis, but transiently decreased the sensitivity of macrophages to toxin. High levels of toxin reduced protein synthesis in human peripheral polymorphonuclear leukocytes but did not alter the ability of these cells to kill P. aeruginosa. Elastase and alkaline protease did not cause release of marker enzymes and did not directly inhibit the bactericidal activity of polymorphonuclear leukocytes; killing was reduced due to inactivation of complement components. In conclusion, these potential virulence products do not modify phagocyte function directly and thus do not directly interfere with host response in pseudomonas infections.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6811122     DOI: 10.1139/m82-102

Source DB:  PubMed          Journal:  Can J Microbiol        ISSN: 0008-4166            Impact factor:   2.419


  9 in total

Review 1.  Cystic fibrosis, pathophysiological and clinical aspects.

Authors:  H J Neijens; M Sinaasappel; R de Groot; J C de Jongste; S E Overbeek
Journal:  Eur J Pediatr       Date:  1990-08       Impact factor: 3.183

2.  In vitro effect of the slime of Pseudomonas aeruginosa on the function of human polymorphonuclear neutrophils.

Authors:  P F Laharrague; J X Corberand; G Fillola; B J Gleizes; A M Fontanilles; E Gyrard
Journal:  Infect Immun       Date:  1984-06       Impact factor: 3.441

3.  Inhibition of human natural killer cell activity by Pseudomonas aeruginosa alkaline protease and elastase.

Authors:  B K Pedersen; A Kharazmi
Journal:  Infect Immun       Date:  1987-04       Impact factor: 3.441

4.  Type II secretion system of Pseudomonas aeruginosa: in vivo evidence of a significant role in death due to lung infection.

Authors:  Jeevan Jyot; Viviane Balloy; Gregory Jouvion; Amrisha Verma; Lhousseine Touqui; Michel Huerre; Michel Chignard; Reuben Ramphal
Journal:  J Infect Dis       Date:  2011-05-15       Impact factor: 5.226

Review 5.  Molecular Mechanisms Involved in Pseudomonas aeruginosa Bacteremia.

Authors:  Stéphane Pont; Manon Janet-Maitre; Eric Faudry; François Cretin; Ina Attrée
Journal:  Adv Exp Med Biol       Date:  2022       Impact factor: 3.650

6.  Pseudomonas aeruginosa exoproteases inhibit human neutrophil chemiluminescence.

Authors:  A Kharazmi; N Høiby; G Döring; N H Valerius
Journal:  Infect Immun       Date:  1984-06       Impact factor: 3.441

7.  Interaction of Pseudomonas aeruginosa alkaline protease and elastase with human polymorphonuclear leukocytes in vitro.

Authors:  A Kharazmi; G Döring; N Høiby; N H Valerius
Journal:  Infect Immun       Date:  1984-01       Impact factor: 3.441

8.  Dual-function vaccine for Pseudomonas aeruginosa: characterization of chimeric exotoxin A-pilin protein.

Authors:  R Hertle; R Mrsny; D J Fitzgerald
Journal:  Infect Immun       Date:  2001-11       Impact factor: 3.609

9.  Pseudomonas aeruginosa LasB Subverts Alveolar Macrophage Activity by Interfering With Bacterial Killing Through Downregulation of Innate Immune Defense, Reactive Oxygen Species Generation, and Complement Activation.

Authors:  Fabien Bastaert; Saadé Kheir; Vinciane Saint-Criq; Bérengère Villeret; Pham My-Chan Dang; Jamel El-Benna; Jean-Claude Sirard; Romé Voulhoux; Jean-Michel Sallenave
Journal:  Front Immunol       Date:  2018-07-23       Impact factor: 7.561

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.